SCHEMBL722930

SCHEMBL722930

ClCCNCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3861975 0.96
SCHEMBL12922020 0.78
SCHEMBL5769531 0.75
SCHEMBL2571537 0.75
SCHEMBL7261786 0.70
Hydrochloric Acid SCHEMBL28636041 0.70
Hydrochloric Acid SCHEMBL14738714 0.70
Nornitrogen Mustard SCHEMBL24674 0.67
SCHEMBL8514969 0.67
SCHEMBL11983269 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101024681-A Method for preparing fluorine-contained multi-function epoxy resin UNIV DONGHUA (CN) 2007-08-29 CN claimed
US-5004808-A Aminoalkyl-derivatives of hydroxyalkyl-celluloses DOMTAR INC. 1991-04-02 US claimed
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS TRINEURO (KR) 2024-01-18 US disclosed
CN-113135869-B Method for preparing alpha-aryl carbonyl compound and product 浙江师范大学 2022-06-10 CN disclosed
CN-113135869-A Method for preparing alpha-aryl carbonyl compound and product 浙江师范大学 2021-07-20 CN disclosed
US-9809604-B2 DGAT1 inhibitor and preparation method and use thereof QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD. (CN) 2017-11-07 US disclosed
EP-2423201-B1 Luminescent macrocyclic lanthanide complexes UNIV CALIFORNIA (US) 2017-10-04 EP disclosed
US-9708303-B2 LFA-1 inhibitor and methods of preparation and polymorph thereof SARCODE BIOSCIENCE INC. (US) 2017-07-18 US disclosed
US-9580383-B2 Compositions and methods for the treatment of multiple sclerosis CELLIX BIO PRIVATE LIMITED (IN) 2017-02-28 US disclosed
US-20170029410-A1 CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF SARCODE BIOSCIENCE INC. (US) 2017-02-02 US disclosed
US-20160368902-A1 CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF SARCODE BIOSCIENCE INC. (US) 2016-12-22 US disclosed
US-8080562-B2 Crystalline pharmaceutical and methods of preparation and use thereof SARCODE BIOSCIENCE INC. (US) 2011-12-20 US disclosed
WO-2010142507-A2 ADHESIVE COMPOSITION KITOZYME S.A. (BE) 2010-12-16 WO disclosed
US-20100035870-A1 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds CYCLACEL LIMITED (GB) 2010-02-11 US disclosed
US-20090298869-A1 Crystalline pharmaceutical and methods of preparation and use thereof CITIBANK, N.A., AS NOTES COLLATERAL AGENT 2009-12-03 US disclosed
US-20080234237-A1 QUINOLONE AND TETRAHYDROQUINOLONE AND RELATED COMPOUNDS HAVING NOS INHIBITORY ACTIVITY NEURAXON, INC. (CA) 2008-09-25 US disclosed
US-20070232577-A1 Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin ADVANCED LIFE SCIENCES, INC. (US) 2007-10-04 US disclosed
CN-101024681-A Method for preparing fluorine-contained multi-function epoxy resin UNIV DONGHUA (CN) 2007-08-29 CN disclosed
US-5427777-A Phosphonium salt with sites effective for binding bile acid anions linked to crosslinked non-digestible polymer backbone LOWCHOL SCIENTIFIC, INC. (CA) 1995-06-27 US disclosed
US-5189111-A AMINOALKYLATED SIDE-CHAINS-CONTAINING VINYLIC COPOLYMERS SANDOZ LTD. (CH) 1993-02-23 US disclosed